Author details

Full Name

Claudia Gebhard

Affiliation

University Hospital Regensburg

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34591983	Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.	Int J Cancer	2022
35606086	Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-ÎºB activation.	J Immunother Cancer	2022
36161919	Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.	Proc Natl Acad Sci U S A	2022
35879286	Postmitotic differentiation of human monocytes requires cohesin-structured chromatin.	Nat Commun	2022
35073416	Physiological levels of 25-hydroxyvitamin D<sub>3</sub> induce a suppressive CD4<sup>+</sup> T cell phenotype not reflected in the epigenetic landscape.	Scand J Immunol	2022
34636987	Interplay between adipose tissue secreted proteins, eating behavior and obesity.	Eur J Nutr	2022
33081589	Associations of site-specific CD4<sup><b>+</b></sup>-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus.	Lupus	2021
33789089	Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory TÂ cells.	Immunity	2021
33563611	The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.	Cancer Immunol Res	2021
33692344	The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites.	Nat Commun	2021
33831168	Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML.	Blood	2021
34284675	Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: A cross-sectional association study.	Lupus	2021
32098963	Author Correction: Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.	Nat Commun	2020
31964861	Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.	Nat Commun	2020
31378787	C-Jun drives melanoma progression in PTEN wild type melanoma cells.	Cell Death Dis	2019
29925905	Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.	Leukemia	2019
29154771	In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors.	J Immunol Methods	2018
30315124	Temporal autoregulation during human PU.1 locus SubTAD formation.	Blood	2018
28829439	An integrated expression atlas of miRNAs and their promoters in human and mouse.	Nat Biotechnol	2017
26966090	An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.	Blood	2016
25886572	Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains.	Genome Biol	2015
24670763	An atlas of active enhancers across human cell types and tissues.	Nature	2014
23705593	5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes.	Genome Biol	2013
20145141	General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.	Cancer Res	2010
20565882	Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels.	Genome Biol	2010
16778185	Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.	Cancer Res	2006
16822855	Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.	Nucleic Acids Res	2006

1 - 27 of 27

Hui Shen

Van Andel Institute

Career Start Year 2010

Number of shared co-authors 0

Daniel D De Carvalho

Princess Margaret Cancer Centre, University Health Network

Career Start Year 2010

Number of shared co-authors 0

Pavlo Lutsik

Catholic University (KU) Leuven

Career Start Year 2010

Number of shared co-authors 2

Benjamin G Barwick

Emory University School of Medicine

Career Start Year 2009

Number of shared co-authors 0

Lukas Chavez

University of California San Diego

Career Start Year 2008

Number of shared co-authors 1

Eleni M Tomazou

St. Anna Children's Cancer Research Institute (CCRI)

Career Start Year 2007

Number of shared co-authors 1

Yassen Assenov

German Cancer Research Center (DKFZ)

Career Start Year 2006

Number of shared co-authors 2

Yue Lu

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 0

David Klinkebiel

University of Nebraska Medical Center

Career Start Year 2005

Number of shared co-authors 0

Brock C Christensen

Geisel School of Medicine, Dartmouth College

Career Start Year 2005

Number of shared co-authors 0

Christoph Bock

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences

Career Start Year 2005

Number of shared co-authors 5

Duncan Sproul

Institute of Genetics and Cancer, University of Edinburgh

Career Start Year 2004

Number of shared co-authors 0

J??rg Tost

CEA-Institut de Biologie Francois Jacob, Universite Paris-Saclay

Career Start Year 2002

Number of shared co-authors 2

Ting Wang

Washington University School of Medicine

Career Start Year 2001

Number of shared co-authors 1

Benjamin P Berman

Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem

Career Start Year 2000

Number of shared co-authors 1

Francine E Garrett-Bakelman

University of Virginia

Career Start Year 1999

Number of shared co-authors 0

Michal R Schweiger

Institute for Translational Epigenetics, University of Cologne

Career Start Year 1999

Number of shared co-authors 1

Martin Hirst

University of British Columbia

Career Start Year 1998

Number of shared co-authors 1

Marina Bibikova

Departments of Bioinformatics and Clinical Genomics, Illumina Inc.

Career Start Year 1998

Number of shared co-authors 2

Tim H-M Huang

University of Texas Health San Antonio (UTHSA)

Career Start Year 1997

Number of shared co-authors 0

Bradley E Bernstein

Broad Institute of MIT and Harvard

Career Start Year 1994

Number of shared co-authors 0

Jean-Pierre J Issa

Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine

Career Start Year 1993

Number of shared co-authors 0

Joseph F Costello

University of California san francisco

Career Start Year 1991

Number of shared co-authors 2

Holger Heyn

Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra

Career Start Year 1988

Number of shared co-authors 1

Dieter Weichenhan

German Cancer Research Center (DKFZ)

Career Start Year 1988

Number of shared co-authors 6

Kornel E Schuebel

National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health

Career Start Year 1985

Number of shared co-authors 0

Peter W Laird

Van Andel Institute

Career Start Year 1985

Number of shared co-authors 0

Richard R Meehan

Institute of Genetics and Molecular Medicine, University of Edinburgh

Career Start Year 1984

Number of shared co-authors 1

Stephan Beck

UCL Cancer Institute, University College London

Career Start Year 1983

Number of shared co-authors 5

Christoph Plass

German Cancer Research Center

Career Start Year 1982

Number of shared co-authors 6

row(s) 1 - 30 of 30

Michael Rehli

University Hospital Regensburg

Co-authored papers 25

Johanna Raithel

Leibniz Institute for Immunotherapy, c/o University Hospital Regensburg

Co-authored papers 7

Dagmar Glatz

University Hospital Regensburg

Co-authored papers 6

Lucia Schwarzfischer

University Hospital Regensburg

Co-authored papers 6

Christian Schmidl

Leibniz Institute for Immunotherapy

Co-authored papers 5

Matthias Edinger

Regensburg University Hospital

Co-authored papers 4

Rainer Spang

University of Regensburg

Co-authored papers 3

Carsten O Daub

International Institute of Molecular and Cell Biology in Warsaw

Co-authored papers 2

Yoshihide Hayashizaki

Center for Integrative Medical Sciences

Co-authored papers 2

Erik Arner

RIKEN Center for Integrative Medical Sciences (IMS)

Co-authored papers 2

Alexander Maxwell Burroughs

National Center for Biotechnology Information, National Institutes of Health

Co-authored papers 2

Christopher J Mungall

International Society for Biocuration, Lawrence Berkeley National Laboratory, University of Edinburgh, University of Edinburgh School of Biological Sciences

Co-authored papers 2

Timo Lassmann

Telethon Kids Institute, University of Western Australia

Co-authored papers 2

Nicolas Bertin

University Bordeaux, CNRS

Co-authored papers 2

Albin Sandelin

University of Copenhagen

Co-authored papers 2

Piero Carninci

RIKEN Center for Integrative Medical Sciences